Molecules

Thyroid Science
A online journal dedicated to truth in thyroid science and clinical practice

ABOUT US | Home | Journal Staff | Editorials & Latest Postings | Search Engine |
SUBMISSIONS | Authors' Guidelines | How to Submit Papers | How to Submit Letters |
SECTIONS | Criticism | Case Reports | Debate | Clinical & Lab Studies | Hypotheses | Letters | Reviews |

Letters Related to Dr. Lowe's Rebuttal to the British Thyroid Association
Want to be notified about new publications in Thyroid Science?
Email:
For Email Marketing you can trust

Letters below are posted in descending order. The first letter below has the earliest date, and the last one has the latest date.

To submit a letter to an editor or author through Thyroid Science, please read our guidelines for submitting letters. Submit your letter to Editor@thyroidscience.com. Letters may be edited and shortened. Thank you.

| General Letters Dr. Allahabadia's Reply |



Subject: Reply to rebuttal to the BTA's opinions
From: editor@thyroidscience.com
Date: Mon, March 15, 2010 9:01 am
To: Amit.Allahabadia@sth.nhs.uk
Secretary, British Thyroid Association
-----------------------------------------

Dear Dr. Allahabadia,

I initially wrote to you in March 16, 2009—one year ago—asking that the
British Thyroid Association (BTA) respond to my rebuttal
<http://www.thyroidscience.com/Criticism/lowe.3.16.09/bta.rebuttal.htm> to its opinions on levothyroxine, T4/T3 combination therapy, and desiccated
thyroid. You wrote back to me in August 2009 saying that the BTA would
respond “in due course.”

I consider that due course has long since passed. If the BTA does not
enter discourse over its opinions, then its opinions can justifiably be
considered authoritative and dogmatic rather than rational and
scientifically-based.

I request once more that the BTA reply to the various points in my
rebuttal. Considering how long it has been since I initially wrote to the
BTA, a prompt response from the BTA is imperative. The reason is that many
practitioners are likely to accept without question that the BTA’s
opinions are scientifically accurate. Because some of the BTA’s opinions,
expressed in its Executive Committee’s document, are patently false, which
I documented in my rebuttal, some of these practitioners may make
decisions on behalf of hypothyroid patients that adversely affect the
health and well-fare of hypothyroid patients.

It is in the interest of quality care for hypothyroid patients, and in the
spirit of traditional scientific values, that I ask again that the BTA to
reply to my rebuttal.

Sincerely,
Dr. John C. Lowe
Editor-in-Chief
Thyroid Science

Subject: RE: Request for reply from the British Thyroid Association
From: Amit.Allahabadia@sth.nhs.uk
Date: Tue, April 7, 2009 4:22 am
To: editor@thyroidscience.com

Dear Dr Lowe

Thank you for e-mail. The Executive Committee of the British Thyroid
Association will consider your comments in due course in consultation
with The Royal College of Physicians.

Best wishes
Dr Amit Allahabadia
Secretary of The British Thyroid Association


Subject: Request for reply from the British Thyroid Association
From: editor@thyroidscience.com
Date: Tue, April 7, 2009 4:11 am
To: Amit.Allahabadia@sth.nhs.uk

To: Dr Amit Allahabadia
Secretary: British Thyroid Association
Sheffield Teaching Hospitals, Sheffield

Dear Dr. Allahabadia,

Below is an email I send to you and the British Thyroid Association
(BTA) on March 16, 2009. In the email, I invited a response from the BTA to
be published without censorship at Thyroid Science in the spirit of
scientific discourse. I have not received a response from you or from any
other representative of the BTA. I will be grateful if you or another
representative will give us the courtesy of letting us know, at minimum,
that you received my email, but hopefully also letting us know whether we
can expect a response from the BTA. Thank you for taking the time to
reply.

For your convenience, below is the webpage address to my rebuttal to the
BTA's document on natural desiccated thyroid and synthetic T4/T3
therapies:

http://www.thyroidscience.com/Criticism/lowe.3.16.09/bta.rebuttal.htm

Best regards,
Dr. John C. Lowe
Board Certified: American Academy of Pain Management
Director of Research: Fibromyalgia Research Foundation
Editor-in-Chief: ThyroidScience.com
(603) 391-6061, www.drlowe.com
drlowe@drlowe.com Tammy@drlowe.com
drlowe@FibromyalgiaResearch.org


Subject: Rebuttal to British Thyroid Association's document on natural desiccated thyroid
From: editor@thyroidscience.com
Date: Mon, March 16, 2009 2:12 pm
To: Amit.Allahabadia@sth.nhs.uk

To: Dr Amit Allahabadia
Secretary: British Thyroid Association
Sheffield Teaching Hospitals, Sheffield

Dear Dr. Allahabadia,

I have included below a link to a rebuttal I have written to the British
Thyroid Association (BTA). The rebuttal concerns the BTA Executive
Committee's 2007 document on natural desiccated thyroid and levothyroxine.
After having critically analyzed the Committee's document, I believe it
constitutes a gross disservice to patients and clinicians who might read
and be mislead by its unbalanced presentation of evidence and the false
statements it contains. I feel it is proper to let the BTA know about my
rebuttal so that its officials can respond, hopefully by correcting the
misinformation the 2007 document contains. We at Thyroid Science, of
course, will be happy to publish any statement the BTA decide to make in
response to the rebuttal.

http://www.thyroidscience.com/Criticism/lowe.3.16.09/bta.rebuttal.htm

All best wishes,

Sincerely,
Dr. John C. Lowe
Board Certified: American Academy of Pain Management
Director of Research: Fibromyalgia Research Foundation
Editor-in-Chief: ThyroidScience.com
(603) 391-6061, www.drlowe.com
drlowe@drlowe.com Tammy@drlowe.com
drlowe@FibromyalgiaResearch.org


© 2010 Thyroid Science